Cargando…
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
BACKGROUND: Epigenetic alterations and loss of heterozygosity are mechanisms of tumor suppressor gene inactivation. A new carcinogenic pathway, targeting the RAS effectors has recently been documented. RASSF1A, on 3p21.3, and NORE1A, on 1q32.1, are among the most important, representative RAS effect...
Autores principales: | Lázcoz, Paula, Muñoz, Jorge, Nistal, Manuel, Pestaña, Ángel, Encío, Ignacio, Castresana, Javier S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634754/ https://www.ncbi.nlm.nih.gov/pubmed/17064406 http://dx.doi.org/10.1186/1471-2407-6-254 |
Ejemplares similares
-
In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines
por: Blanco-Luquin, Idoia, et al.
Publicado: (2021) -
Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment
por: Celay, Jon, et al.
Publicado: (2013) -
Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas
por: Muñoz, Jorge, et al.
Publicado: (2012) -
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012) -
Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)